Encap Neuroscience is developing a brain-computer interface that uses patient-specific signals to rewire the brain and help it heal. The Numbray platform is envisioned as the world's first home-based neuromodulation device and ecosystem, providing a wearable alternative for mental health treatment. The technology addresses the 2 million Australians currently diagnosed with depression, anxiety, ADHD, and addiction. Neuromodulation has been proven far more effective than anti-depressant medications but is typically only offered as a second-line treatment due to accessibility challenges. The company partners with psychiatrists, scientists, engineers, and designers. Joined the Remarkable Accelerator Program in 2018, supported by Cerebral Palsy Alliance.

Mental Health, Neurotechnology, Brain-Computer Interface, Neuromodulation